The Latest Breaking News from Pfizer

Israel has started administering doses of the new COVID-19 vaccine tailored to fight the highly infectious omicron variant

JPMorgan analyst Eric Joseph slashed his price target on Novavax by more than $100, to $27 per share.

Biden’s recent announcement that the pandemic is ending could slow process further, as parents question the necessity of shots

A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 18 strange trades.

In their most severe - and rare - forms, myocarditis and pericarditis can result in chronic heart failure or death. But what is the link between the condition and Covid vaccines?

Some of the nation's pharmacies are reporting shortages of Moderna Inc.’s new bivalent booster shot for COVID-19 as one factory used in producing the vaccine remains offline following a safety inspection.

Norton, Baptist begin offering new COVID-19 boosters

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK),…

The depressing outcome of the split is a legal challenge in the US over Zantac that will run on for years

Modern matron nurse May Parsons injected the first ever dose of the Pfizer vaccine into 90-year-old grandmother Maggie Keenan on December 8, 2020, at Coventry Hospital

Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between six months and four years, the government body said in a statement Friday night.